|ITEM METADATA RECORD
|Title: ||Renal Safety of Zoledronic Acid (ZOL) In Patients (pts) Starting ZOL Therapy and Beyond 2 Years of Treatment - a Prospective Multi-center Evaluation|
|Authors: ||Van den Wyngaert, T|
Wildiers, Hans #
|Issue Date: ||Sep-2011 |
|Publisher: ||Elsevier sci ltd|
|Host Document: ||European journal of cancer vol:47 pages:S240-S240|
|Conference: ||European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care Stockholm, SWEDEN, SEP 23-27, 2011|
|Publication status: ||published|
|KU Leuven publication type: ||IMa|
|Appears in Collections:||Embryo and Stemcells (-)|
Laboratory of Experimental Oncology
|Files in This Item:
There are no files associated with this item.
All items in Lirias are protected by copyright, with all rights reserved.
© Web of science